Skip to content

IRIS study - The IUGR Risk Selection Study.

IRIS study - The IUGR Risk Selection Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23334
Enrollment
15000
Registered
2014-03-20
Start date
2015-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perinatal death Severe perinatal morbidity IUGR - Intra Uterine Growth Restriction SGA - Small for Gestational Age

Interventions

In all midwifery practices, growth will be monitored using standardised symphysis fundal height (SFH) measurement. In the intervention strategy two routine US examinations will be performed (between 2

Sponsors

VU University Medical Center Amsterdam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria MIDWIFERY PRACTICES: 1) midwives have received the post registration training on the new KNOV guideline ‘detection of IUGR’; 2) those who will perform the biometry US have passed tests on quality fetal US. Inclusion criteria PREGNANT WOMEN: 1) negative 20 week US screening test result; 2) singleton pregnancy; 3) receiving care in primary care at 22 weeks gestation.

Exclusion criteria

Exclusion criteria: Exclusion criteria PREGNANT WOMEN: Women without dating US who do not have a reliable estimated date of delivery (EDD).

Design outcomes

Primary

MeasureTime frame
The clinical primary outcome is a dichotomous composite measure ‘severe adverse perinatal outcome’ up to 7 days after birth, including: perinatal death; Apgar score below 4 at 5 minutes after birth; impaired consciousness; asphyxia; neonatal seizures; need for assisted ventilation for more than 24 hours; septicaemia; meningitis; bronchopulmonary dysplasia; intraventricular haemorrhage; cystic periventricular leukomalacia; or necrotizing enterocolitis. Also direct and indirect costs are primary outcomes.

Secondary

MeasureTime frame
COMPOSITE secondary outcomes 1. Spontaneous vaginal birth without intervention, i.e. a birth without any of the following: - induction of labour other than amniotomy - vacuum/ forceps - caesarean section - augmentation of labour - pharmacological pain relief: epidural anaesthesia or use of opioids 2. Maternal morbidity, defined as the presence of one or more of the following: - maternal death within 42 days after giving birth - hypertension - pre-eclampsia - postpartum haemorrhage - third or fourth degree perineal trauma SINGULAR secondary outcomes: - elements of composite primary outcome - elements of the two composite secondary outcomes - birth weight - gestational age at birth - neonatal mortality and severe morbidity between 7th and 28th day after birth - detection of congenital abnormalities - home and hospital birth in primary care - non-cephalic presentations (when labour started) in primary care - general quality of life - EQ-5D-5L - pregnancy specific anxiety - PRAQ - depression - EPDS - maternal-fetal attachment - MAAS - client satisfaction - subscale of PCQ

Contacts

Public Contactirisstudie@vumc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)